BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B).

Saved in:
Bibliographic Details
Title: BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B).
Authors: Sakai H; Advanced Cancer Translational Research Institute, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. sakai-h@med.showa-u.ac.jp., Kusumoto-Matsuo R; Advanced Cancer Translational Research Institute, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan., Hosonaga M; Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Nozawa K; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan., Futamura M; Department of Breast Surgery, Gifu University Hospital, Gifu, Japan., Tanabe Y; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Mukohara T; Department of Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Shiraishi K; Department of Medical Oncology, NHO Nagoya Medical Center, Nagoya, Japan., Toyama T; Department of Breast Surgery, Nagoya City University, Nagoya, Japan., Yasojima H; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan., Watanabe N; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan., Sakai H; Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan., Iwasa T; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan., Takeuchi N; Department of Oncology, Ina Central Hospital, Ina, Japan., Tada H; Department of Surgery, Division of Breast and Endocrine Surgery, Tohoku University Hospital, Sendai, Japan., Sakai K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka, Japan., Chiba N; Department of Cancer Biology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan., Takano T; Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Tsurutani J; Advanced Cancer Translational Research Institute, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 May; Vol. 33 (3), pp. 790-797. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1880-4233
DOI:10.1007/s12282-026-01855-2